MetaADEDB 2.0 @ LMMD
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
(VQLPLYSROCPWFF-QZTJIDSGSA-N)
Structure
SMILES
O=C(N([C@@H]1CCCC[C@H]1N1CCCC1)C)Cc1ccc(c(c1)Cl)Cl
Molecular Formula:
C19H26Cl2N2O
Molecular Weight:
369.329
Log P:
4.3392
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
0
TPSA:
23.55
CAS Number(s):
67198-13-4; 308240-58-6
Synonym(s)
1.
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
2.
Benzeneacetamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, (trans)-Isomer
3.
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+)-Isomer
4.
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Mesylate, (trans)-(+-)-Isomer
5.
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monohydrochloride, (trans)-(+-)-Isomer,
6.
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-(+)-Isomer
7.
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-(+-)-Isomer
8.
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide Monomethanesulfonate, (trans)-Isomer
9.
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1R-cis)-Isomer
10.
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (1S-cis)-Isomer
11.
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(+-)-Isomer
12.
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-benzeneacetamide, (trans)-(-)-Isomer
13.
U-50,488H
14.
U-50488
15.
U-50488H
16.
U50488H
17.
trans-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide
18.
trans-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide Hydrochloride
19.
U 50,488H
20.
U 50488
21.
U 50488H
22.
U50,488H
23.
U50488
External Link(s)
MeSHD019900
PubChem Compound3036289
BindingDB50000296
ChEBI73358
CHEMBLCHEMBL441765
IUPHAR/BPS Guide to PHARMACOLOGY1652
KEGGcpd:C11796
Therapeutic Target DatabaseD0J1PJ
ZINC643032
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Alcohol Withdrawal Seizures16923153CTD
2Bradycardia2568424CTD
3Brain Injuries9495877CTD
4Cocaine-Related Disorders

View details

10911926
18575850
19747933
20232055
 		CTD
5Diarrhea2540324CTD
6Dyskinesia, Drug-Induced17335811CTD
7Epilepsy, Temporal Lobe9495877CTD
8Hyperalgesia

View details

2010815
10087027
15037816
17225166
 		CTD
9Hypotension2568424
11698066		CTD
10Muscle hypotonia18699797CTD
11Neuralgia15037816CTD
12Pain12467995
18699797		CTD
13Vomiting17335811CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.